Accessing GLP-1 treatment in Madera, California has traditionally meant longer waits than mainland patients face. Zepbound® is the FDA-approved Injectable pen Tirzepatide product by Eli Lilly. Weight Method's telehealth model is a separate program built for distance: licensed providers evaluate eligibility, and compounded Tirzepatide (dispensed by a U.S.-licensed 503A pharmacy) ships to any Madera address at $329/month. Compounded Tirzepatide is not FDA-approved.
FDA-approved Zepbound prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Madera is already seeing results
Zepbound in Madera, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Zepbound to patients in Madera from $329/month with virtual consultations and direct-to-door shipping.
Zepbound® by Eli Lilly is the FDA-approved Injectable pen Tirzepatide product, taken Once weekly and approved in 2023 for Chronic weight management. Tirzepatide works by mimicking incretin hormones that regulate hunger and satiety, reducing appetite and helping you feel full with smaller portions. Weight Method is a separate telehealth program for Madera residents: licensed providers evaluate eligible patients and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program starts at $329/month and includes the provider evaluation, the medication, ongoing care, and home delivery.
Research suggests Tirzepatide therapy is studied across diverse populations, and outcomes can improve when care is culturally informed. In Madera, Weight Method pairs compounded Tirzepatide treatment (dispensed by a U.S.-licensed 503A pharmacy; compounded Tirzepatide is not FDA-approved) with bilingual support that respects cultural context, from dietary guidance that accounts for traditional foods to communication in the language you are most comfortable with. The program starts at $329/month.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in California and start Zepbound from $329/month.
Get Started NowFree consultation. No commitment.